معرفی
Renate van Griethuysen serves as an Assistant Professor in the medical field at Utrecht University, specifically within the University Medical Center Utrecht (UMC Utrecht). Her academic work is anchored in the institution's Brain strategic program, where she contributes to epilepsy research through clinical investigations and collaborative studies aimed at improving patient management protocols for seizure disorders.
Her research centers on critical aspects of epilepsy care, particularly antiseizure medication withdrawal practices and presurgical diagnostic procedures. She investigates risk estimation models for seizure recurrence following medication discontinuation, analyzes clinical practice patterns in medication management, and evaluates the diagnostic yield and safety of prolonged video-EEG monitoring for surgical candidates. This work directly addresses gaps in evidence-based guidelines for optimizing treatment decisions while minimizing patient risks.
Recent publications from 2022-2023 reveal a cohesive research trajectory focused on refining clinical decision-making in epilepsy management. Her studies published in Neurology: Clinical Practice, Epilepsia Open, and Epileptic Disorders demonstrate methodological rigor in analyzing real-world practice patterns, developing risk assessment frameworks, and evaluating diagnostic procedures—collectively advancing the field's understanding of treatment optimization and surgical evaluation protocols.
Dr. van Griethuysen maintains active collaborations with leading epilepsy researchers including Kees P.J. Braun, Charlotte J.J. van Asch, and Willem M. Otte, as evidenced by co-authorship across multiple high-impact studies. While specific details about her supervisees and grant funding are not disclosed in available materials, her consistent publication output indicates substantial involvement in multidisciplinary research projects addressing critical challenges in epilepsy therapeutics.
Within UMC Utrecht's organizational structure, she participates in the Brain strategic program's epilepsy research initiative, working alongside neurologists, neurosurgeons, and clinical researchers to translate findings into improved diagnostic and treatment approaches for patients with refractory seizure disorders.
